Janssen sponsored digital GU Debates 2020
20 October 2020

Janssen sponsored digital GU Debates 2020

The meeting will be focused on current challenges and recent advances in the management of GU cancers and on how we can improve the lives of those we treat by focusing on aspects such as the psychological and physical impact of treatments or on the patient support network. Moreover, if you register for this event, you will receive a confirmation ...

more info...

EM-30025
ON-DEMAND webinar: Advanced prostate cancer – how do we move forward in patient management?
30 September 2020 - 156 Minutes

ON-DEMAND webinar: Advanced prostate cancer – how do we move forward in patient management?

Learning objectives:         

After attending this symposium, participants should be able to:

  • Review the current management strategies for metastatic hormone-sensitive prostate cancer (mHSPC) to optimise patient care
  • Discuss the impact of new data on treatment and management decisions forindividual patients with non-metastatic castration-resistant prostate cancer(nmCRPC) and metastatic castration-resistant prostate cancer (mCRPC)
  • Describe considerations ...
more info...

EM-39340
ON-DEMAND webinar: Intrinsic and acquired resistance to EGFR TKIs: new therapies on the horizon
30 September 2020 - 123 Minutes

ON-DEMAND webinar: Intrinsic and acquired resistance to EGFR TKIs: new therapies on the horizon

Learning objectives:         

After attending this symposium, participants should be able to:

  • Highlight the importance of intrinsic and acquired EGFR resistance mutations in NSCLC and how this can impact patient outcomes
  • Understand the increasing role of genetic and molecular profiling and biomarkers in tailoring therapy
  • Describe how current and future research in the ...
more info...

EM-39341
Bladder cancer news September 2020: an expert view
23 September 2020 - 1 Hours

Bladder cancer news September 2020: an expert view

Learning objective:         

After attending this meeting, participants should be able to:

  • Discuss and explain the new data on bladder cancer
  • Integrate the discussed data into the current bladder cancer landscape

 

Scientific Committee:

  • Alison Birtle (UK)
  • Ignacio Duran (Spain)

 

Faculty:

  • Morgan Roupret (France)
  • Yohann Loriot (France)
more info...

EM-39337
Prostate cancer news September 2020: an expert view
22 September 2020 - 62 Minutes

Prostate cancer news September 2020: an expert view

Learning objective:         

After attending this webinar, participants should be able to:

  • Discuss and explain the new data on prostate cancer
  • Discuss how the new data will affect daily clinical practice

 

Scientific Committee:

  • Kurt Miller (Germany)
  • Heather Payne (UK)

 

Faculty:

  • Amit Bahl (UK)
  • Oliver Sartor (US)
more info...

EM-39335
Current scientific questions influencing patient management in advanced prostate cancer
17 July 2020 - 1 Hours

Current scientific questions influencing patient management in advanced prostate cancer

Learning objective:         

After joining this meeting, participants should be able to:

  • Describe the clinical benefits of earlier treatment of patients with metastatic hormone-sensitive prostate cancer (mHSPC) and non-metastatic castration-resistant prostate cancer (nmCRPC) and the consequences of disease progression
  • Discuss the impact of new data on treatment and management decisions for ...
more info...

EM-26511
Prostate cancer news June 2020: an expert view
3 June 2020 - 61 Minutes

Prostate cancer news June 2020: an expert view

Learning objectives:         

After watching this broadcast, participants should be able to:

  • Discuss and explain the new data on prostate cancer
  • Discuss how the new data will affect daily clinical practice

 

Scientific committee:

  • Heather Payne, UK
  • Kurt Miller, Germany

 

more info...

EM-31420
Prostate cancer news June 2020: an expert view
2 June 2020 - 61 Minutes

Prostate cancer news June 2020: an expert view

Learning objectives:         

After watching this broadcast, participants should be able to:

  • Discuss and explain the new data on prostate cancer
  • Discuss how the new data will affect daily clinical practice

 

Scientific committee:

  • Heather Payne, UK
  • Kurt Miller, Germany

 

more info...

EM-31420
The COVID-19 pandemic: implications for patients with advanced prostate cancer
6 May 2020 - 1 Hours

The COVID-19 pandemic: implications for patients with advanced prostate cancer

Learning objective:         

After watching this broadcast, participants should be able to:

  • Evaluate the management options for advanced prostate cancer patients during the current COVID-19 pandemic
  • Discuss the impact of the COVID-19 pandemic on patients and HCPs

 

Scientific committee:

  • Heather Payne, UK
  • Kurt Miller, Germany

 

more info...

EM -31245